Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E 2 production in HaCaT cells

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 2, 2012, Pages 252-258

  Huang, Jin ^a   Ding, Li ^b   Shi, Duo ^b   Hu, Jin Hong ^a   Zhu, Quan Gang ^a   Gao, Shen ^a   Qiu, Lei ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ginsenoside Rg1; interleukin 8; keratinocyte; prostaglandin E 2; transient receptor potential vanilloid 1

Indexed keywords

CYCLOOXYGENASE 2; FLUO 3; GINSENOSIDE RG 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LUCIFERASE; PROSTAGLANDIN E2; VANILLOID RECEPTOR 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ASSAY; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; GENE OVEREXPRESSION; INTRACELLULAR SIGNALING; KERATINOCYTE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR BLOCKING; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CALCIUM; CAPSAICIN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM AGENTS; CYCLOOXYGENASE 2; DINOPROSTONE; DRUGS, CHINESE HERBAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GINSENOSIDES; HEK293 CELLS; HUMANS; INTERLEUKIN-8; KERATINOCYTES; NF-KAPPA B; TRPV CATION CHANNELS;

EID: 84855421392     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01392.x     Document Type: Article

References (34)

1. Li L, et al,. High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. Biomed Chromatogr 2006; 20: 327-335.
2. Ng TB,. Pharmacological activity of sanchi ginseng (Panax notoginseng). J Pharm Pharmacol 2006; 58: 1007-1019. (Pubitemid 44213633)
3. Surh YJ, et al,. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-kappaB and ERK1/2 in mouse skin. Ann N Y Acad Sci 2002; 973: 396-401.
4. Wang Y, et al,. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1. Acta Pharmacol Sin 2000; 21: 792-796.
5. Stander S, et al,. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004; 13: 129-139. (Pubitemid 38380276)
6. Caterina MJ, et al,. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-824. (Pubitemid 27462969)
7. Hayes P, et al,. Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain 2000; 88: 205-215.
8. Davis JB, et al,. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000; 405: 183-187. (Pubitemid 30313536)
9. Southall MD, et al,. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003; 304: 217-222. (Pubitemid 36008931)
10. Seki N, et al,. Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells. Life Sci 2007; 80: 1592-1597. (Pubitemid 46412362)
11. Lee LY, et al,. Role of TRPV1 in inflammation-induced airway hypersensitivity. Curr Opin Pharmacol 2009; 9: 243-249.
12. Bodo E, et al,. Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol 2004; 123: 410-413. (Pubitemid 38951840)
13. Bodo E, et al,. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005; 166: 985-998. (Pubitemid 40524424)
14. Stander S, et al,. Neurophysiology of pruritus: cutaneous elicitation of itch. Arch Dermatol 2003; 139: 1463-1470. (Pubitemid 37441284)
15. Alappatt C, et al,. Acute keratinocyte damage stimulates platelet-activating factor production. Arch Dermatol Res 2000; 292: 256-259. (Pubitemid 30265051)
16. Kemeny L, et al,. The interleukin-8 receptor: a potential target for antipsoriatic therapy? Eur J Pharmacol 1994; 258: 269-272. (Pubitemid 24179990)
17. Kupper TS,. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 1990; 94: 146S-150S. (Pubitemid 20213084)
18. Gunthorpe MJ, et al,. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov Today 2009; 14: 56-67.
19. Khairatkar-Joshi N, et al,. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol Med 2009; 15: 14-22.
20. Lee JH, et al,. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci Lett 2002; 325: 129-133.
21. Lee E, et al,. 20(S)-ginsenoside Rh2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur J Pharmacol 2006; 536: 69-77.
22. Rhim H, et al,. Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons. Eur J Pharmacol 2002; 436: 151-158. (Pubitemid 34164694)
23. Huang J, et al,. Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE production in a human keratinocyte cell line HaCaT. Int Immunopharmacol 2010; 10: 1279-1283.
24. Gavva NR, et al,. AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3- dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 2005; 313: 474-484. (Pubitemid 40411374)
25. Lehto SG, et al,. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3- dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(tri fluoromethyl)phenyl)- acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J Pharmacol Exp Ther 2008; 326: 218-229. (Pubitemid 351872146)
26. Kim HA, et al,. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int Immunopharmacol 2007; 7: 1286-1291. (Pubitemid 47126366)
27. Kawahira K, et al,. Effects of ginsenoside Rb1 at low doses on histamine, substance P, and monocyte chemoattractant protein 1 in the burn wound areas during the process of acute burn wound repair. J Ethnopharmacol 2008; 117: 278-284.
28. Hahn J, et al,. Ginsenosides inhibit capsaicin-activated channel in rat sensory neurons. Neurosci Lett 2000; 287: 45-48. (Pubitemid 30332374)
29. Harkey MR, et al,. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001; 73: 1101-1106. (Pubitemid 32496951)
30. Oh U, et al,. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J Neurosci 1996; 16: 1659-1667. (Pubitemid 26145943)
31. Nagy I, et al,. Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin. J Neurosci 1999; 19: 10647-10655. (Pubitemid 30235711)
32. Guo YS, et al,. Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells. J Biol Chem 2001; 276: 22941-22947.
33. Bazan HE, et al,. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci 1997; 38: 2492-2501. (Pubitemid 27492750)
34. Kaltschmidt B, et al,. Signaling via NF-kappaB in the nervous system. Biochim Biophys Acta 2005; 1745: 287-299. (Pubitemid 41330783)